M. A. Nieto

Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply.

L. León, L. Abasolo, O. Sanchez-Pernaute, 2020, Rheumatology.

Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.

L. León, L. Abasolo, J. Jover, 2020, Rheumatology.

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis.

N. Mena-Vázquez, I. Castellví, M. A. Nieto, 2022, Reumatologia clinica.

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment.

N. Mena-Vázquez, I. Castellví, M. A. Nieto, 2022, Reumatologia clinica.

Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns

L. León, L. Abasolo, J. Jover, 2021, BMC Pulmonary Medicine.

Functional respiratory impairment and related factors in patients with interstitial pneumonia with autoimmune features (IPAF): Multicenter study from NEREA registry

L. León, F. Romero-Bueno, M. J. Rodríguez-Nieto, 2023, Respiratory Research.